Amplitude, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Amplitude, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	68.4	102	167	238	276	299	343
Cost of revenue	22.1	30.5	51.8	70.4	71.9	76.9	89.3
Gross profit	46.3	72	115	168	204	222	254
Research and development	19	26.1	48.3	80.6	90.1	97.6	97.6
Selling and marketing	47.1	51.8	86	130	154	168	188
General and administrative	14.6	18.1	55.4	53.6	54.9	63.9	64.3
Operating expenses	80.7	96	190	264	307	330	350
Other non-operating income	1.46	0.27	0.2	3.98	13.4	14.9	10.7
Pre-tax income	-32.9	-23.7	-74	-92.6	-89.1	-92.5	-85.3
Income tax	0.66	0.83	1.03	0.8	1.27	1.79	3.21
Net income	-33.5	-24.6	-75	-93.4	-90.4	-94.3	-88.5
EPS, basic	-1.38	-0.98	-1.46	-0.84	-0.77	-0.76	-0.67
EPS, diluted	-1.38	-0.98	-1.46	-0.84	-0.77	-0.76	-0.67
Shares, basic (weighted)	24.3	25.1	51.4	111	117	124	132
Shares, diluted (weighted)	24.3	25.1	51.4	111	117	124	132

Balance sheet

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	79.8	118	307	218	248	172	81.1
Short-term investments			0	12	73.9	69.4	111
Receivables		17.4	20.4	22.7	29.5	26.3	23.4
Other current assets		6.86	19.1	20.3	16.6	20.4	22.9
Total current assets		149	355	284	380	304	257
Property, plant and equipment		2.67	4.83	9.41	10.1	16.3	18.6
Lease right-of-use assets			0	9.59	6.86	5.29	9.05
Goodwill		1	4.07	4.07	4.07	24.4	25.2
Intangible assets		1.96	3.55	2.02	0.61	4.36	6.38
Long-term investments			0	71.2	0	57.2	60.5
Other non-current assets		6.9	11.4	6.35	4.3	6.99	8.26
Total assets		175	400	414	434	446	421
Accounts payable		4.42	3.36	0.49	3.06	0.99	5.73
Accrued liabilities		8.11	17.9	18.7	26.7	33.9	37.1
Deferred revenue		40.8	69.3	90	103	110	122
Total current liabilities		53.3	90.6	109	132	145	165
Lease liabilities			0	7.09	3.6	1.77	6.88
Other non-current liabilities			3.25	2.51	3.03	3.07	3.71
Total liabilities		54.4	93.8	119	139	149	175
Paid-in capital		37.7	486	569	658	754	791
Retained earnings		-105	-180	-273	-364	-458	-546
Other comprehensive income			0	-0.75	-0.18	0.01	0.59
Shareholders' equity	-62.9	-67.1	307	295	295	297	245
Total equity	-62.9	-67.1	307	295	295	297	245
Total liabilities and equity		175	400	414	434	446	421

Cash flow statement

	FY2019	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-33.5	-24.6	-75	-93.4	-90.4	-94.3	-88.5
Depreciation and amortization	0.72	1.69	3.09	4.66	5.62	6.11	9.61
Stock-based compensation	7.33	16.6	34.4	67.2	88.3	100	92.1
Deferred income tax	0.66	0.83	1.03	0.8	1.27	1.79	3.21
Change in receivables	-1.17	-5.56	-3.03	-2.43	-8.45	2.21	2.77
Change in payables	0.49	2.41	-1.05	-2.88	2.5	-1.99	4.69
Cash from operations	-16	-10.4	-31.7	-5.38	25.6	18.5	29.8
Capital expenditures	-0.65	-0.98	-1.53	-3.63	-1.28	-1.73	-1.62
Acquisitions	0	-3.7	-1.72	-0.39	0	-16.1	-3.03
Purchases of investments		0	0	-83.2	0	-146	-117
Cash from investing	-0.65	-5.91	-1.5	-89.4	9.32	-75.4	-55.1
Stock issued	0.38	4.43	21.8	6.91	4.62	6.51	4.88
Share buybacks					-0.65	0	-30.7
Cash from financing	0.87	54.2	223	5.83	-4.94	-19.9	-65.3
Net change in cash	-15.8	37.9	189	-88.9	30	-76.8	-90.6
Free cash flow	-16.7	-11.4	-33.2	-9.02	24.4	16.8	28.2
Income taxes paid	0.06	0.22	0.18	0.42	0.45	0.49	0.97

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $13.30 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	72.4%	Gross profit / revenue.
Pre-tax margin	-25.5%	Pre-tax income / revenue.
Net margin	-26.6%	Net income / revenue.
FCF margin	7.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	8.5%	Cash from operations / revenue.
Return on equity (ROE)	-73.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-27.9%	Net income / average total assets.
R&D / revenue	29.1%	Research and development expense / revenue.
Stock-based pay / revenue	25.1%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.6%	Capital expenditures / revenue.
D&A / revenue	2.9%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	14.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	13.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	27.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	14.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	14.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	28.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	61.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	68.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-17.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-6.0%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	-5.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	19.2%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	6.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	5.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	39.4%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.05x	Current assets / current liabilities.
Quick ratio	0.85x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.67x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	61.8%	Total liabilities / total assets.
Working capital	$9.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	11.4%	(Goodwill + intangible assets) / total assets.
Tangible book value	$95.5M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.05x	Revenue / average total assets.
Fixed asset turnover	19.8x	Revenue / average property, plant and equipment.
Receivables turnover	9.99x	Revenue / average receivables.
Days sales outstanding	37 days	365 x average receivables / revenue.
Days payables	3 days	365 x average accounts payable / cost of revenue.
Capex / operating cash flow	7.3%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.77	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$2.89	Revenue / diluted weighted shares.
FCF per share	$0.23	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.25	Cash from operations / diluted weighted shares.
Book value per share	$1.05	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$0.74	Tangible book value / shares outstanding.
Cash per share	$1.09	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	399.6%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.66B	Share price x shares outstanding.
Enterprise value	$1.52B	Market cap + total debt - cash - short-term investments.
P/S	4.44x	Market cap / revenue.
P/B	12.2x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	17.4x	Market cap / tangible book value, when positive.
P/FCF	56.4x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	52.3x	Market cap / cash from operations, when positive.
EV/Sales	4.06x	Enterprise value / revenue.
EV/FCF	51.7x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.8%	Free cash flow / market cap.
Earnings yield	-6.0%	Net income / market cap (the inverse of P/E).
Shareholder yield	7.1%	(Dividends paid + share buybacks) / market cap.

What was Amplitude, Inc.'s revenue in fiscal 2025?

Amplitude, Inc. reported revenue of $343.2M for fiscal 2025, 14.7% higher than the year before.

Was Amplitude, Inc. profitable in fiscal 2025?

No. It reported a net loss of $88.5M.

How much free cash flow did Amplitude, Inc. generate in fiscal 2025?

Cash from operations of $29.8M minus capital expenditures of $1.6M left free cash flow of $28.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Amplitude, Inc.